廣鋼氣體(688548.SH):擬建設空分氣體智能裝備製造基地項目
格隆匯2月18日丨廣鋼氣體(688548.SH)公佈,為打造自主可控的裝備製造生產基地,逐步建立和掌握自有的裝備設計核心技術、生產能力,提升廣鋼氣體的核心競爭力,2024年2月8日,公司與建德市人民政府簽訂《空分氣體智能裝備製造基地項目投資協議書》,擬在建德經濟開發區內建設空分氣體智能裝備製造基地項目,項目規劃分兩期建設,其中一期擬投資金額15,687萬元,建設期約為18個月,預計在2025年7月建成投產。二期項目建設將根據產品訂單需求、公司業務發展情況、外部市場環境等因素綜合判斷另行決策和建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.